SG
ELV icon

Sankala Group’s Elevance Health ELV Stock Holding History

Sankala Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.23K Sell
13
-1
-7% -$371 ﹤0.01% 459
2026
Q1 		$4.03K Sell
14
-5
-26% -$1.64K ﹤0.01% 445
2025
Q4 		$6.08K Buy
+19
New +$6.42K ﹤0.01% 436

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sankala Group's ELV Position: Q2 2026 in Review

Sankala Group reduced its Elevance Health (ELV) stake by 7.1% in Q2 2026, selling an estimated $371 and leaving 13 shares worth $5.23K. The position accounts for ﹤0.01% of the portfolio, ranked #459.

Sankala Group first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.08K in Q4 2025. 1,611 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Sankala Group held 13 shares of Elevance Health worth $5.23K as of Q2 2026.
  • Sankala Group sold 1 Elevance Health share in Q2 2026, an estimated $371.
  • Elevance Health made up ﹤0.01% of Sankala Group's portfolio in Q2 2026, its #459 holding.
  • Sankala Group first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • Sankala Group's Elevance Health position peaked at $6.08K in Q4 2025.
  • 1,611 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Sankala Group's 13F filing for Q2 2026, filed 18 Aug 2026.